Steroidogenesis of cultured granulosa cells in women at risk for ovarian hyperstimulation syndrome
- PMID: 1459265
- DOI: 10.1016/s0015-0282(16)55561-7
Steroidogenesis of cultured granulosa cells in women at risk for ovarian hyperstimulation syndrome
Abstract
Objective: To determine if cultured human granulosa cells (GCs) obtained from women at risk for ovarian hyperstimulation syndrome (OHSS) possess altered steroidogenic capacity.
Design: Prospective analysis of 28 consecutive in vitro fertilization-gamete intrafallopian transfer (IVF-GIFT) cycles.
Setting: In Vitro Fertilization Program at Rush Presbyterian St. Luke's Medical Center in Chicago, Illinois.
Patients: Eighteen patients (group I) with serum estradiol (E2) levels > 7,342 pmol/L on the day of exogenous human chorionic gonadotropin (hCG) administration (day 0) with > 10 ovarian follicles present (high risk for OHSS); 10 patients (group II) with E2 < or = 7,342 pmol/L on day 0 and < or = 10 follicles.
Interventions: Human GCs obtained during gonadotropin-releasing hormone agonist-pretreated IVF-GIFT cycles were cultured in the absence (control) or presence (hCG) of hCG, 1 IU/mL, and/or androstenedione (A) 10(-7) M. Granulosa cells obtained from follicles < or = 15 mm diameter were cultured separately from those obtained from follicles > 15 mm diameter.
Main outcome measures: Estradiol (E2) and progesterone were measured in tissue-culture medium by a solid-phase direct radioimmunoassay.
Results: In vitro E2 production by cultured GCs was significantly increased in follicles < or = 15 mm diameter from women considered at risk of developing OHSS (group I). Estradiol response to hCG and/or A appeared enhanced in all follicles in group I. Progesterone production in the basal and hCG challenged state was greater in cells obtained from large follicles in group I than in group II.
Conclusion: Ovarian hyperstimulation syndrome appears to be a function of an increased number of follicles that express an enhanced steroidogenic capacity.
Similar articles
-
Serum and follicular fluid (FF) estradiol (E2) levels in ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) conception cycles after pituitary suppression.J In Vitro Fert Embryo Transf. 1991 Jun;8(3):137-40. doi: 10.1007/BF01131702. J In Vitro Fert Embryo Transf. 1991. PMID: 1919258
-
Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.Am J Obstet Gynecol. 1995 May;172(5):1518-25. doi: 10.1016/0002-9378(95)90490-5. Am J Obstet Gynecol. 1995. PMID: 7755066
-
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.PLoS One. 2016 Mar 7;11(3):e0149615. doi: 10.1371/journal.pone.0149615. eCollection 2016. PLoS One. 2016. PMID: 26950065 Free PMC article.
-
Melatonin stimulates aromatase expression and estradiol production in human granulosa-lutein cells: relevance for high serum estradiol levels in patients with ovarian hyperstimulation syndrome.Exp Mol Med. 2020 Aug;52(8):1341-1350. doi: 10.1038/s12276-020-00491-w. Epub 2020 Aug 27. Exp Mol Med. 2020. PMID: 32855437 Free PMC article.
-
The prevention of ovarian hyperstimulation syndrome.J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5. J Obstet Gynaecol Can. 2014. PMID: 25574681 Review. English, French.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources